Natera (NTRA) Cost of Revenue (2014 - 2026)
Natera's (NTRA) quarterly Cost of Revenue came in at $266.6 million in Q2 2026, up 33.61% on a YoY basis from $199.5 million in Q2 2025, and up 8.73% quarter-over-quarter from $245.2 million in Q1 2026.
Analysis
Natera (NTRA) Cost of Revenue (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported Cost of Revenue for 13 consecutive years, with $266.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cost of Revenue rose 33.61% year-over-year to $266.6 million; the trailing twelve-month figure through Jun 2026 stood at $938.3 million (up 28.93% YoY), and the FY2025 full-year result was $810.6 million, up 20.57% from the prior year.
- Cost of Revenue climbed to $266.6 million in Q2 2026 per NTRA's latest filing, from $245.2 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $266.6 million in Q2 2026 and bottomed at $102.7 million in Q1 2022.
- Historically, Cost of Revenue has averaged $168.7 million across 5 years, with a median of $163.2 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Cost of Revenue jumped 55.96% in 2022, then climbed 7.5% in 2024.
- Over 5 years, Cost of Revenue stood at $126.8 million in 2022, then grew by 19.14% to $151.0 million in 2023, then grew by 16.5% to $176.0 million in 2024, then increased by 24.59% to $219.2 million in 2025, then gained by 21.61% to $266.6 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $266.6 million, $245.2 million, and $219.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 266.60 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 2.02 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 2.62 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 115.95 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 108.23 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 81.33 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 143.41 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 32.34 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 20.17 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 60.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 266.60 Mn |
| Mar 31, 2026 | 245.20 Mn |
| Dec 31, 2025 | 219.23 Mn |
| Sep 30, 2025 | 207.25 Mn |
| Jun 30, 2025 | 199.53 Mn |
| Mar 31, 2025 | 184.61 Mn |
| Dec 31, 2024 | 175.96 Mn |
| Sep 30, 2024 | 167.66 Mn |
| Jun 30, 2024 | 169.85 Mn |
| Mar 31, 2024 | 158.83 Mn |
| Dec 31, 2023 | 151.04 Mn |
| Sep 30, 2023 | 146.96 Mn |
| Jun 30, 2023 | 142.81 Mn |
| Mar 31, 2023 | 147.75 Mn |
| Dec 31, 2022 | 126.77 Mn |
| Sep 30, 2022 | 115.44 Mn |
| Jun 30, 2022 | 108.76 Mn |
| Mar 31, 2022 | 102.67 Mn |
| Dec 31, 2021 | 93.33 Mn |
| Sep 30, 2021 | 80.51 Mn |